U.S. regulators approved 39 new drugs in 2012, the most in 16 years, suggesting that pharmaceutical makers are poised for growth after losing billions of dollars in recent years to generic drug makers because of patent expirations.
FDA new drug approvals hit 16-year high in 2012
Send us a letter
Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.